It is now well established that clinical use of statins for primary and secondary prevention of cardiovascular complications in patients with diabetes mellitus (DM) increases life expectancy. At the same time, meta-analysis of major randomized trials shows statins to increase glycemic levels and incidence of diabetic symptoms, especially in patients at risk for developing glycemic disorders. However, comparison of positive and negative effects of statins suggests prevalence of clinically beneficial factors.
分享
引用
